Cite
HARVARD Citation
Ghosh, J. et al. (n.d.). EP216/#881 Safety and tolerability of olaparib in Indian patients with ovarian cancer: the prospective, single-arm, phase 4 soli trial. International journal of gynecological cancer. p. A137. [Online].